[go: up one dir, main page]

AR002272A1 - Uso de amidas de fenilciclohexilcarboxilicos - Google Patents

Uso de amidas de fenilciclohexilcarboxilicos

Info

Publication number
AR002272A1
AR002272A1 ARP960101106A AR10110696A AR002272A1 AR 002272 A1 AR002272 A1 AR 002272A1 AR P960101106 A ARP960101106 A AR P960101106A AR 10110696 A AR10110696 A AR 10110696A AR 002272 A1 AR002272 A1 AR 002272A1
Authority
AR
Argentina
Prior art keywords
phenylcyclohexylcarboxylic
amides
medicaments
restenosis
formula
Prior art date
Application number
ARP960101106A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR002272A1 publication Critical patent/AR002272A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Las amidas de ácidos fenilciclohexilcarboxílicos de fórmula (I) conocidas, son adecuadas como sustancia activa en medicamentos, especialmente enmedicamentos para el tratamiento de la restenosis.
ARP960101106A 1995-02-01 1996-01-22 Uso de amidas de fenilciclohexilcarboxilicos AR002272A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19503160A DE19503160A1 (de) 1995-02-01 1995-02-01 Verwendung von Phenylcyclohexylcarbonsäureamiden

Publications (1)

Publication Number Publication Date
AR002272A1 true AR002272A1 (es) 1998-03-11

Family

ID=7752849

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101106A AR002272A1 (es) 1995-02-01 1996-01-22 Uso de amidas de fenilciclohexilcarboxilicos

Country Status (31)

Country Link
US (1) US5935983A (es)
EP (1) EP0725064A1 (es)
JP (1) JPH08253453A (es)
KR (1) KR960031442A (es)
CN (1) CN1137380A (es)
AR (1) AR002272A1 (es)
AU (1) AU710235B2 (es)
BG (2) BG63044B1 (es)
CA (1) CA2168317A1 (es)
CZ (1) CZ29196A3 (es)
DE (1) DE19503160A1 (es)
DZ (1) DZ1986A1 (es)
EE (1) EE9600023A (es)
FI (1) FI960425A7 (es)
HR (1) HRP960017A2 (es)
HU (1) HUP9600227A3 (es)
IL (1) IL116931A (es)
MA (1) MA23794A1 (es)
NO (1) NO309841B1 (es)
NZ (1) NZ280905A (es)
PL (1) PL312546A1 (es)
RO (1) RO117256B1 (es)
RU (1) RU2158261C2 (es)
SG (1) SG42329A1 (es)
SK (1) SK13796A3 (es)
SV (1) SV1996000008A (es)
TN (1) TNSN96016A1 (es)
TW (1) TW448176B (es)
UA (1) UA35623C2 (es)
YU (1) YU5896A (es)
ZA (1) ZA96725B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911462B2 (en) * 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
DE19924818A1 (de) 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
DE19924819A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren)
PT1368028E (pt) * 2001-03-12 2007-11-26 Avanir Pharmaceuticals Compostos de benzimidazole para modulação de ige e inibição da proliferação celular
DE10150310A1 (de) * 2001-10-11 2003-04-24 Bayer Ag Substituierte Piperazincyclohexancarbonsäureamide und ihre Verwendung
US6934951B2 (en) 2002-01-17 2005-08-23 Intel Corporation Parallel processor with functional pipeline providing programming engines by supporting multiple contexts and critical section
TW200304820A (en) * 2002-03-25 2003-10-16 Avanir Pharmaceuticals Use of benzimidazole analogs in the treatment of cell proliferation
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
TWI276631B (en) * 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
FR2852957B1 (fr) * 2003-03-31 2005-06-10 Sod Conseils Rech Applic Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament
JO2355B1 (en) * 2003-04-15 2006-12-12 ميرك شارب اند دوم كوربوريشن Hereditary calcitonin polypeptide receptor antagonists
WO2005013950A2 (en) * 2003-08-08 2005-02-17 Avanir Pharmaceuticals Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4224133A1 (de) * 1992-07-22 1994-01-27 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4226109A1 (de) * 1992-08-07 1994-02-10 Bayer Ag Verwendung von ASS zur Hemmung von Plaquebildung
DE4304455A1 (de) * 1993-02-15 1994-08-18 Bayer Ag Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
US5358959A (en) * 1993-02-18 1994-10-25 President And Fellows Of Harvard University Methods for treating arteriosclerosis
DE4401893A1 (de) * 1994-01-24 1995-07-27 Bayer Ag Substituierte Arylharnstoffe

Also Published As

Publication number Publication date
SK13796A3 (en) 1996-10-02
SV1996000008A (es) 1996-11-04
HUP9600227A3 (en) 2000-03-28
NO309841B1 (no) 2001-04-09
US5935983A (en) 1999-08-10
RO117256B1 (ro) 2001-12-28
NZ280905A (en) 1996-12-20
ZA96725B (en) 1996-08-20
BG63044B1 (bg) 2001-02-28
FI960425L (fi) 1996-08-02
RU2158261C2 (ru) 2000-10-27
IL116931A0 (en) 1996-05-14
NO960414D0 (no) 1996-01-31
AU4224096A (en) 1996-08-08
SG42329A1 (en) 1997-08-15
TW448176B (en) 2001-08-01
DZ1986A1 (fr) 2002-10-15
UA35623C2 (uk) 2001-04-16
JPH08253453A (ja) 1996-10-01
TNSN96016A1 (fr) 2005-03-15
BG103820A (bg) 2001-09-28
CA2168317A1 (en) 1996-08-02
BG100326A (bg) 1996-08-30
CN1137380A (zh) 1996-12-11
YU5896A (sh) 1998-12-23
EP0725064A1 (de) 1996-08-07
IL116931A (en) 2000-06-01
NO960414L (no) 1996-08-02
FI960425A0 (fi) 1996-01-30
PL312546A1 (en) 1996-08-05
KR960031442A (ko) 1996-09-17
AU710235B2 (en) 1999-09-16
CZ29196A3 (en) 1996-08-14
HRP960017A2 (en) 1997-12-31
MA23794A1 (fr) 1996-10-01
EE9600023A (et) 1996-08-15
HU9600227D0 (en) 1996-03-28
HUP9600227A2 (en) 1996-12-30
FI960425A7 (fi) 1996-08-02
DE19503160A1 (de) 1996-08-08

Similar Documents

Publication Publication Date Title
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
PT923570E (pt) Amidas de acidos piridil-alcenoicos e piridil-alcinicos como agentes citostaticos e imunossupressivos
ES2147320T3 (es) Derivados de n-(3-benzofuranil)urea.
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
ES2096673T3 (es) Uso de sulfonamidas como medicamentos y nuevas sulfonamidas.
SV2002000097A (es) Inhibidores de metaloproteasas ref.pcs10322/82940 /bb
ES2191192T3 (es) Tienopirimidinas.
HN1998000035A (es) Nuevos derivados del acido hexanoico
ATE249214T1 (de) Pentafluorobenzensulfonamide und analoge
AR007828A1 (es) Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos
SV1995000062A (es) DERIVADOS DE CICLOALCANO-INDOL Y - AZAINDOL REF. Le A 30 699
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
SV1995000007A (es) Derivados del acido micofenolico 5-substituidos.
AR002272A1 (es) Uso de amidas de fenilciclohexilcarboxilicos
SV2003001148A (es) Derivados de benzamida tiazol y composciones farmaceuticas para inhibir la proliferacion de celulas, y metodos para su utilizacion ref. no.0097-01-sv
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
AR008860A1 (es) Empleo de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.
AR021694A1 (es) Retinamidas de acido 7-aril-6-(z)heptatrienoico

Legal Events

Date Code Title Description
FC Refusal